Banner

Earnings and Investment

>

Latest News

RenovoRx increases production of RenovoCath: ©Wrightstudio - stock.adobe.com
RenovoRx increases production of RenovoCath device to meet growing demand

April 16th 2025

RenovoCath is designed to deliver diagnostic and therapeutic agents directly to targeted tissues, offering a localized approach to treatment that can minimize systemic exposure.

J&J reports positive results: ©Yanina - stock.adobe.com
Johnson & Johnson’s MedTech Division posts solid Q1 growth

April 15th 2025

The Trump tariff induced stock market downturn: What investors should keep in mind
The Trump tariff induced stock market downturn: What investors should keep in mind

April 8th 2025

NeuroOne announces public offering, speeds up timeline for its trigeminal nerve ablation system
NeuroOne announces public offering, speeds up timeline for its trigeminal nerve ablation system

April 4th 2025

VIPs touring SHL Medical's new South Carolina plant: ©SHL Medical
SHL Medical opens state-of-the-art manufacturing facility in South Carolina

April 3rd 2025

More News

Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio

Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio

Medical Economics Staff
April 2nd 2025

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

MicroTransponder secures $65 million to expand stroke recovery therapy: ©MicroTransponder

MicroTransponder secures $65 million to expand stroke recovery therapy

Todd Shryock
March 18th 2025

Investment will support the expansion of its FDA-approved therapy designed to improve upper extremity function in chronic ischemic stroke survivors.